The Utility of a Wireless Implantable Hemodynamic Monitoring System in Patients Requiring Mechanical Circulatory Support

被引:25
|
作者
Feldman, David S. [1 ,4 ]
Moazami, Nader [2 ]
Adamson, Philip B. [3 ]
Vierecke, Juliane [4 ]
Raval, Nir [5 ]
Shreenivas, Satya [1 ]
Cabuay, Barry M. [6 ]
Jimenez, Javier [7 ]
Abraham, William T. [8 ]
O'Connell, John B. [3 ]
Naka, Yoshifumi [9 ]
机构
[1] Univ Cincinnati, Med Ctr, Div Cardiovasc Med, Cincinnati, OH USA
[2] Cleveland Clin Fdn, Cardiothorac Surg, 9500 Euclid Ave, Cleveland, OH 44195 USA
[3] St Jude Med, Sect Adv Med Therapies, St Paul, MN USA
[4] Univ Bern, Div Cardiol, Bern, Switzerland
[5] Florida Hosp Transplant Inst, Orlando, FL USA
[6] Minneapolis Heart Inst, Dept Cardiol, Minneapolis, MN USA
[7] South Miami Hosp, Div Cardiol, South Miami, FL USA
[8] Ohio State Univ, Med Ctr, Div Cardiovasc Med, Columbus, OH 43210 USA
[9] Columbia Univ, Med Ctr, Div Cardiothorac Surg, New York, NY USA
关键词
hemodynamic monitoring; mechanical circulatory support; left ventricular assist device; heart failure; pulmonary wedge pressure; heart transplantation; PULMONARY-ARTERY PRESSURE; ADVANCED HEART-FAILURE; INTERMACS ANNUAL-REPORT; DEVICE; EFFICACY; THERAPY; TRIAL;
D O I
10.1097/MAT.0000000000000670
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Proper timing of left ventricular assist device (LVAD) implantation in advanced heart failure patients is not well established and is an area of intense interest. In addition, optimizing LVAD performance after implantation remains difficult and represents a significant clinical need. Implantable hemodynamic monitoring systems may provide physicians with the physiologic information necessary to improve the timing of LVAD implantation as well as LVAD performance when compared with current methods. The CardioMEMS Heart sensor Allows for Monitoirng of Pressures to Improve Outcomes in NYHA Class III heart failure patients (CHAMPION) Trial enrolled 550 previously hospitalized patients with New York Heart Association (NYHA) class III heart failure. All patients were implanted with a pulmonary artery (PA) pressure monitoring system and randomized to a treatment and control groups. In the treatment group, physicians used the hemodynamic information to make heart failure management decisions. This information was not available to physicians for the control group. During an average of 18 month randomized follow-up, 27 patients required LVAD implantation. At the time of PA pressure sensor implantation, patients ultimately requiring advanced therapy had higher PA pressures, lower systemic pressure, and similar cardiac output measurements. Treatment and control patients in the LVAD subgroup had similar clinical profiles at the time of enrollment. There was a trend toward a shorter length of time to LVAD implantation in the treatment group when hemodynamic information was available. After LVAD implantation, most treatment group patients continued to provide physicians with physiologic information from the hemodynamic monitoring system. As expected PA pressures declined significantly post LVAD implant in all patients, but the magnitude of decline was higher in patients with PA pressure monitoring. Implantable hemodynamic monitoring appeared to improve the timing of LVAD implantation as well as optimize LVAD performance when compared with current methods. Further studies are necessary to evaluate these findings in a prospective manner.
引用
收藏
页码:301 / 308
页数:8
相关论文
共 50 条
  • [21] Permanent mechanical circulatory support in patients of advanced age
    Jurmann, MJ
    Weng, Y
    Drews, T
    Pasic, M
    Hennig, E
    Hetzer, R
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 25 (04) : 610 - 618
  • [22] Oral surgical management of patients with mechanical circulatory support
    Lund, JP
    Drews, T
    Hetzer, R
    Reichart, PA
    INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2002, 31 (06) : 629 - 633
  • [23] Mechanical circulatory support for elderly heart failure patients
    Butler, Craig R.
    Jugdutt, Bodh I.
    HEART FAILURE REVIEWS, 2012, 17 (4-5) : 663 - 669
  • [24] Outcomes of Mechanical Circulatory Support in HIV Infected Patients
    Blumer, Vanessa
    Ortiz, Miguel
    Hernandez, Gabriel A.
    Macon, Conrad
    Mendirichaga, Rodrigo
    Lemor, Alejandro
    Chaparro, Sandra
    CIRCULATION, 2017, 136
  • [25] Mechanical circulatory support for elderly heart failure patients
    Craig R. Butler
    Bodh I. Jugdutt
    Heart Failure Reviews, 2012, 17 : 663 - 669
  • [26] Infections in Patients with Mechanical Circulatory Support
    Eichenberger, Emily M.
    Phadke, Varun
    Busch, Lindsay M.
    Pouch, Stephanie M.
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2024, 38 (04) : 693 - 712
  • [27] Mechanical circulatory support in paediatric patients
    Polo, Luz
    Sanchez, Rani
    Aroca, Angel
    CIRUGIA CARDIOVASCULAR, 2016, 23 : 55 - 61
  • [28] Integrated Home Monitoring and Compliance Optimization for Patients with Mechanical Circulatory Support Devices
    Klack, Lars
    Schmitz-Rode, Thomas
    Wilkowska, Wiktoria
    Kasugai, Kai
    Heidrich, Felix
    Ziefle, Martina
    ANNALS OF BIOMEDICAL ENGINEERING, 2011, 39 (12) : 2911 - 2921
  • [29] Status 2 Patients Had Poor Prognosis Without Mechanical Circulatory Support - Indications for Device Implantation -
    Imamura, Teruhiko
    Kinugawa, Koichiro
    Hatano, Masaru
    Fujino, Takeo
    Inaba, Toshiro
    Maki, Hisataka
    Kinoshita, Osamu
    Amiya, Eisuke
    Nawata, Kan
    Yao, Atsushi
    Kyo, Shunei
    Ono, Minoru
    Komuro, Issei
    CIRCULATION JOURNAL, 2014, 78 (06) : 1396 - 1404
  • [30] Integrated Home Monitoring and Compliance Optimization for Patients with Mechanical Circulatory Support Devices
    Lars Klack
    Thomas Schmitz-Rode
    Wiktoria Wilkowska
    Kai Kasugai
    Felix Heidrich
    Martina Ziefle
    Annals of Biomedical Engineering, 2011, 39 : 2911 - 2921